Surgical treatment of stage IV melanoma

Clinics in Dermatology

Volumn 22, Issue 3, 2004, Pages 240-250

  Spanknebel, Kathryn ^a   Kaufman, Howard L ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL METASTASIS; BRAIN METASTASIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CORRELATION ANALYSIS; DISEASE SEVERITY; FUTUROLOGY; HEPATOBILIARY DISEASE; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LUNG METASTASIS; LYMPH NODE METASTASIS; MELANOMA; PATIENT SELECTION; PRIORITY JOURNAL; RADIOSURGERY; REVIEW; SENTINEL LYMPH NODE BIOPSY; SPLENECTOMY; SURGICAL TECHNIQUE; TUMOR GROWTH; VISCERAL METASTASIS;

EID: 3242689707     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2003.12.004     Document Type: Article

References (95)

1. Sharpless S.M., Das Gupta T.K. Surgery for metastatic melanoma. Semin Surg Oncol. 14:1998;311-318
2. Meyer T., Merkel S., Goehl J., Hohenberger W. Surgical therapy for distant metastases of malignant melanoma. Cancer. 89:2000;1983-1991
3. Brountzos E.N., Panagiotou I.E., Bafaloukos D.I., Kelekis D.A. Ultrasonographic detection of regional lymph node metastases in patients with intermediate or thick malignant melanoma. Oncol Rep. 10:2003;505-510
4. Meier F., Will S., Ellwanger U., et al. Metastatic pathways and time courses in the orderly progression of cutaneous melanoma. Br J Dermatol. 147:2002;62-70
5. McDermott V.G., Low V.H., Keogan M.T., Lawrence J.A., Paulson E.K. Malignant melanoma metastatic to the gastrointestinal tract. AJR Am J Roentgenol. 166:1996;809-813
6. Felix E.L., Sindelar W.F., Bagley D.H., Johnston G.S., Ketcham A.S. The use of bone and brain scans as screening procedures in patients with malignant lesions. Surg Gynecol Obstet. 141:1975;867-869
7. Nguyen A.T., Akhurst T., Larson S.M., et al. PET scanning with (18)F 2-fluoro-2-deoxy-D-glucose (FDG) in patients with melanoma. Benefits and limitations. Clin Positron Imaging. 2:1999;93-98
8. Dalrymple-Hay M.J., Rome P.D., Kennedy C., et al. Pulmonary metastatic melanoma - the survival benefit associated with positron emission tomography scanning. Eur J Cardiothorac Surg. 21:2002;611-614
9. Wornom I.L. III, Smith J.W., Soong S.J., et al. Surgery as palliative treatment for distant metastases of melanoma. Ann Surg. 204:1986;181-185
10. Balch C.M., Buzaid A.C., Atkins M.B., et al. A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer. 88:2000;1484-1491
11. Deichmann M., Benner A., Bock M., et al. S100-Beta, melanoma-inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer stage IV melanoma. J Clin Oncol. 17:1999;1891-1896
12. Franzke A., Probst-Kepper M., Buer J., et al. Elevated pretreatment serum levels of soluble vascular cell adhesion molecule 1 and lactate dehydrogenase as predictors of survival in cutaneous metastatic malignant melanoma. Br J Cancer. 78:1998;40-45
13. Balch C.M., Buzaid A.C., Soong S.J., et al. New TNM melanoma staging system linking biology and natural history to clinical outcomes. Semin Surg Oncol. 21:2003;43-52
14. Balch C.M., Soong S.J., Murad T.M., et al. A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III). J Clin Oncol. 1:1983;126-134
15. Leo F., Cagini L., Rocmans P., et al. Lung metastases from melanoma when is surgical treatment warranted? Br J Cancer. 83:2000;569-572
16. Karakousis C.P., Temple D.F., Moore R., Ambrus J.L. Prognostic parameters in recurrent malignant melanoma. Cancer. 52:1983;575-579
17. Harpole D.H. Jr, Johnson C.M., Wolfe W.G., et al. Analysis of 945 cases of pulmonary metastatic melanoma. J Thorac Cardiovasc Surg. 103:1992;743-748
18. Barth A., Wanek L.A., Morton D.L. Prognostic factors in 1,521 melanoma patients with distant metastases. J Am Coll Surg. 181:1995;193-201
19. Feun L.G., Gutterman J., Burgess M.A., et al. The natural history of resectable metastatic melanoma (Stage IVA melanoma). Cancer. 50:1982;1656-1663
20. Garbe C., Paul A., Kohler-Spath H., et al. Prospective evaluation of a follow-up schedule in cutaneous melanoma patients recommendations for an effective follow-up strategy. J Clin Oncol. 21:2003;520-529
21. Morton D.L., Essner R., Balch C. Surgical excision of distant metastases. Balch C., Houghton A. Jr, Sober A., Soong S.J. Cutaneous melanoma. 2003;547-572 Quality Medical Publishing, Inc, St. Louis
22. Wong J.H., Skinner K.A., Kim K.A., et al. The role of surgery in the treatment of nonregionally recurrent melanoma. Surgery. 113:1993;389-394
23. Morris K.T., Marquez C.M., Holland J.M., Vetto J.T. Prevention of local recurrence after surgical debulking of nodal and subcutaneous melanoma deposits by hypofractionated radiation. Ann Surg Oncol. 7:2000;680-684
24. Eton O., Legha S.S., Moon T.E., et al. Prognostic factors for survival of patients treated systemically for disseminated melanoma. J Clin Oncol. 16:1998;1103-1111
25. Ollila D.W., Hsueh E.C., Stern S.L., Morton D.L. Metastasectomy for recurrent stage IV melanoma. J Surg Oncol. 71:1999;209-213
26. Gorenstein L.A., Putnam J.B., Natarajan G., et al. Improved survival after resection of pulmonary metastases from malignant melanoma. Ann Thorac Surg. 52:1991;204-210
27. Pogrebniak H.W., Stovroff M., Roth J.A., Pass H.I. Resection of pulmonary metastases from malignant melanoma results of a 16-year experience. Ann Thorac Surg. 46:1988;20-23
28. Juttner F.M., Smolle J., Pinter H., et al. Solitary coin lesion in patients with malignant melanoma an indication for thoracotomy? Thorac Cardiovasc Surg. 36:1988;232-233
29. Legha S.S., Ring S., Papadopoulos N., et al. A prospective evaluation of a triple-drug regimen containing cisplatin, vinblastine, and dacarbazine (CVD) for metastatic melanoma. Cancer. 64:1989;2024-2029
30. McClay E.F., Mastrangelo M.J., Berd D., Bellet R.E. Effective combination chemo/hormonal therapy for malignant melanoma experience with three consecutive trials. Int J Cancer. 50:1992;553-556
31. Rosenberg S.A., Lotze M.T., Muul L.M., et al. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med. 313:1985;1485-1492
32. Rosenberg S.A., Yang J.C., White D.E., Steinberg S.M. Durability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2 identification of the antigens mediating response. Ann Surg. 228:1998;307-319
33. Wong J.H., Euhus D.M., Morton D.L. Surgical resection for metastatic melanoma to the lung. Arch Surg. 123:1988;1091-1095
34. Pastorino U. Long-term results of lung metastasectomy prognostic analyses based on 5206 cases. The International Registry of Lung Metastases. J Thorac Cardiovasc Surg. 113:1997;37-49
35. Marincola F.M., Mark J.B. Selection factors resulting in improved survival after surgical resection of tumors metastatic to the lungs. Arch Surg. 125:1990;1387-1392
36. Koodziejski L., Goralczyk J., Dyczek S., et al. The role of surgery in lung metastases. Eur J Surg Oncol. 25:1999;410-417
37. Overett T.K., Shiu M.H. Surgical treatment of distant metastatic melanoma. Indications and results. Cancer. 56:1985;1222-1230
38. Tafra L., Dale P.S., Wanek L.A., et al. Resection and adjuvant immunotherapy for melanoma metastatic to the lung and thorax. J Thorac Cardiovasc Surg. 110:1995;119-128
39. Allen P.J., Coit D.G. The surgical management of metastatic melanoma. Ann Surg Oncol. 9:2002;762-770
40. Joseph W.L., Morton D.L., Adkins P.C. Prognostic significance of tumor doubling time in evaluating operability in pulmonary metastatic disease. J Thorac Cardiovasc Surg. 61:1971;23-32
41. Ollila D.W., Stern S.L., Morton D.L. Tumor doubling time a selection factor for pulmonary resection of metastatic melanoma. J Surg Oncol. 69:1998;206-211
42. Essner R. Surgical treatment of malignant melanoma. Surg Clin North Am. 83:2003;109-156
43. Ransohoff J. Surgical management of metastatic tumors. Semin Oncol. 2:1975;21-27
44. Vieth R.G., Odom G.L. Intracranial metastases and their neurosurgical treatment. J Neurosurg. 23:(4):1965;375-383
45. Amer M.H., Al Sarraf M., Baker L.H., Vaitkevicius V.K. Malignant melanoma and central nervous system metastases incidence, diagnosis, treatment and survival. Cancer. 42:1978;660-668
46. Mendez I.M., Del Maestro R.F. Cerebral metastases from malignant melanoma. Can J Neurol Sci. 15:1988;119-123
47. Sampson J.H., Carter J.H. Jr, Friedman A.H., Seigler H.F. Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg. 88:1998;11-20
48. Patchell R.A., Tibbs P.A., Walsh J.W., et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med. 322:1990;494-500
49. Lagerwaard F.J., Levendag P.C., Nowak P.J., et al. Identification of prognostic factors in patients with brain metastases a review of 1292 patients. Int J Radiat Oncol Biol Phys. 43:1999;795-803
50. Patchell R.A., Tibbs P.A., Regine W.F., et al. Postoperative radiotherapy in the treatment of single metastases to the brain a randomized trial. JAMA. 280:1998;1485-1489
51. Brega K., Robinson W.A., Winston K., Wittenberg W. Surgical treatment of brain metastases in malignant melanoma. Cancer. 66:1990;2105-2110
52. Oredsson S., Ingvar C., Stromblad L.G., Jonsson P.E. Palliative surgery for brain metastases of malignant melanoma. Eur J Surg Oncol. 16:1990;451-456
53. Wronski M., Arbit E. Surgical treatment of brain metastases from melanoma a retrospective study of 91 patients. J Neurosurg. 93:2000;9-18
54. Skibber J.M., Soong S.J., Austin L., et al. Cranial irradiation after surgical excision of brain metastases in melanoma patients. Ann Surg Oncol. 3:1996;118-123
55. Hagen N.A., Cirrincione C., Thaler H.T., DeAngelis L.M. The role of radiation therapy following resection of single brain metastasis from melanoma. Neurology. 40:1990;158-160
56. Zacest A.C., Besser M., Stevens G., et al. Surgical management of cerebral metastases from melanoma outcome in 147 patients treated at a single institution over two decades. J Neurosurg. 96:2002;552-558
57. Cattell E., Kelly C., Middleton M.R. Brain metastases in melanoma a European perspective. Semin Oncol. 29:2002;513-517
58. Davey P., O'Brien P. Disposition of cerebral metastases from malignant melanoma implications for radiosurgery. Neurosurgery. 28:1991;8-14
59. Somaza S., Kondziolka D., Lunsford L.D., et al. Stereotactic radiosurgery for cerebral metastatic melanoma. J Neurosurg. 79:1993;661-666
60. Seung S.K., Sneed P.K., McDermott M.W., et al. Gamma knife radiosurgery for malignant melanoma brain metastases. Cancer J Sci Am. 4:1998;103-109
61. Grob J.J., Regis J., Laurans R., et al. Radiosurgery without whole brain radiotherapy in melanoma brain metastases. Club de Cancerologie Cutanee. Eur J Cancer. 34:1998;1187-1192
62. Gieger M., Wu J.K., Ling M.N., et al. Response of intracranial melanoma metastases to stereotactic radiosurgery. Radiat Oncol Investig. 5:1997;72-80
63. Mori Y., Kondziolka D., Flickinger J.C., et al. Stereotactic radiosurgery for cerebral metastatic melanoma factors affecting local disease control and survival. Int J Radiat Oncol Biol Phys. 42:1998;581-589
64. Yu C., Chen J.C., Apuzzo M.L., et al. Metastatic melanoma to the brain prognostic factors after gamma knife radiosurgery. Int J Radiat Oncol Biol Phys. 52:2002;1277-1287
65. Douglas J.G., Margolin K. The treatment of brain metastases from malignant melanoma. Semin Oncol. 29:2002;518-524
66. Ollila D.W., Essner R., Wanek L.A., Morton D.L. Surgical resection for melanoma metastatic to the gastrointestinal tract. Arch Surg. 131:1996;975-979
67. Tessier D.J., McConnell E.J., Young-Fadok T., Wolff B.G. Melanoma metastatic to the colon case series and review of the literature with outcome analysis. Dis Colon Rectum. 46:2003;441-447
68. Agrawal S., Yao T.J., Coit D.G. Surgery for melanoma metastatic to the gastrointestinal tract. Ann Surg Oncol. 6:1999;336-344
69. Gutman H., Hess K.R., Kokotsakis J.A., et al. Surgery for abdominal metastases of cutaneous melanoma. World J Surg. 25:2001;750-758
70. Karakousis C.P., Velez A., Driscoll D.L., Takita H. Metastasectomy in malignant melanoma. Surgery. 115:1994;295-302
71. Wood T.F., DiFronzo L.A., Rose D.M., et al. Does complete resection of melanoma metastatic to solid intra-abdominal organs improve survival? Ann Surg Oncol. 8:2001;658-662
72. Rose D.M., Essner R., Hughes T.M., et al. Surgical resection for metastatic melanoma to the liver the John Wayne Cancer Institute and Sydney Melanoma Unit experience. Arch Surg. 136:2001;950-955
73. de Wilt J.H., McCarthy W.H., Thompson J.F. Surgical treatment of splenic metastases in patients with melanoma. J Am Coll Surg. 197:2003;38-43
74. Gogas J., Mantas D., Gogas H., et al. Metastatic melanoma in the gallbladder report of a case. Surg Today. 33:2003;135-137
75. Dong X.D., DeMatos P., Prieto V.G., Seigler H.F. Melanoma of the gallbladder a review of cases seen at Duke University Medical Center. Cancer. 85:1999;32-39
76. Lo C.Y., van Heerden J.A., Soreide J.A., et al. Adrenalectomy for metastatic disease to the adrenal glands. Br J Surg. 83:1996;528-531
77. Kim S.H., Brennan M.F., Russo P., et al. The role of surgery in the treatment of clinically isolated adrenal metastasis. Cancer. 82:1998;389-394
78. Haigh P.I., Essner R., Wardlaw J.C., et al. Long-term survival after complete resection of melanoma metastatic to the adrenal gland. Ann Surg Oncol. 6:1999;633-639
79. Branum G.D., Epstein R.E., Leight G.S., Seigler H.F. The role of resection in the management of melanoma metastatic to the adrenal gland. Surgery. 109:1991;127-131
80. Morton D.L., Ollila D.W., Hsueh E.C., et al. Cytoreductive surgery and adjuvant immunotherapy a new management paradigm for metastatic melanoma. CA Cancer J Clin. 49:1999;101-106. 65
81. Hsueh E.C., Essner R., Foshag L.J., et al. Prolonged survival after complete resection of disseminated melanoma and active immunotherapy with a therapeutic cancer vaccine. J Clin Oncol. 20:2002;4549-4554
82. Hsueh E.C., Gupta R.K., Yee R., et al. Does endogenous immune response determine the outcome of surgical therapy for metastatic melanoma? Ann Surg Oncol. 7:2000;232-238
83. Morton D.L., Barth A. Vaccine therapy for malignant melanoma. CA Cancer J Clin. 46:1996;225-244
84. Morton D.L., Foshag L.J., Hoon D.S., et al. Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine. Ann Surg. 216:1992;463-482
85. Hsueh E.C., Gupta R.K., Qi K., Morton D.L. Correlation of specific immune responses with survival in melanoma patients with distant metastases receiving polyvalent melanoma cell vaccine. J Clin Oncol. 16:1998;2913-2920
86. Jones R.C., Kelley M., Gupta R.K., et al. Immune response to polyvalent melanoma cell vaccine in AJCC stage III melanoma an immunologic survival model. Ann Surg Oncol. 3:1996;437-445
87. Morton D.L., Hsueh E.C., Essner R., et al. Prolonged survival of patients receiving active immunotherapy with Canvaxin therapeutic polyvalent vaccine after complete resection of melanoma metastatic to regional lymph nodes. Ann Surg. 236:2002;438-448
88. Hena M.A., Emrich L.J., Nambisan R.N., Karakousis C.P. Effect of surgical treatment on stage IV melanoma. Am J Surg. 153:1987;270-275
89. Markowitz J.S., Cosimi L.A., Carey R.W., et al. Prognosis after initial recurrence of cutaneous melanoma. Arch Surg. 126:1991;703-707
90. Gadd M.A., Coit D.G. Recurrence patterns and outcome in 1019 patients undergoing axillary or inguinal lymphadenectomy for melanoma. Arch Surg. 127:1992;1412-1416
91. Thayer J.O. Jr, Overholt R.H. Metastatic melanoma to the lung long-term results of surgical excision. Am J Surg. 149:1985;558-562
92. Khadra M.H., Thompson J.F., Milton G.W., McCarthy W.H. The justification for surgical treatment of metastatic melanoma of the gastrointestinal tract. Surg Gynecol Obstet. 171:1990;413-416
93. Ihde J.K., Coit D.G. Melanoma metastatic to stomach, small bowel, or colon. Am J Surg. 162:1991;208-211
94. Ricaniadis N., Konstadoulakis M.M., Walsh D., Karakousis C.P. Gastrointestinal metastases from malignant melanoma. Surg Oncol. 4:1995;105-110
95. Berger A.C., Buell J.F., Venzon D., Baker A.R., Libutti S.K. Management of symptomatic malignant melanoma of the gastrointestinal tract. Ann Surg Oncol. 6:1999;155-160